Radosavljević, Aleksandra (56993158000)Aleksandra (56993158000)RadosavljevićJakšić, Vesna (23667666000)Vesna (23667666000)JakšićPezo, Lato (8415644100)Lato (8415644100)PezoKovačević-Pavićević, Dragana (36598720300)Dragana (36598720300)Kovačević-PavićevićIlić, Aleksandra (57382479700)Aleksandra (57382479700)IlićMihailović Vučinić, Violeta (13410407800)Violeta (13410407800)Mihailović Vučinić2025-06-122025-06-122017https://doi.org/10.3109/09273948.2016.1167224https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969263222&doi=10.3109%2f09273948.2016.1167224&partnerID=40&md5=a16e826e607d55270a8cbc7bcf6797d1https://remedy.med.bg.ac.rs/handle/123456789/6689Purpose: To analyze clinical characteristics of ocular sarcoidosis in a group of biopsy-proven sarcoid patients treated at the single referral center for sarcoidosis in Serbia. Methods: A prospective study carried out on 88 biopsy-proven sarcoid patients between January 2012 and December 2014. All patients underwent complete ophthalmological examination. Results: Ocular sarcoidosis was present in 32 patients (36.4% of all) and included: eyelid skin lesions (2.3%); orbital inflammation (2.3%); conjunctival lesions (7.9%); anterior uveitis (2.3%); intermediate uveitis (1.1%); posterior uveitis (15.9%); panuveitis (5.7%), and neuro-ophthalmologic manifestations (9.1%). Complications included cataract (20.4%); glaucoma (5.7%); cystoid macular edema (3.4%); epiretinal membrane formation (4.5%); macular atrophy (2.3%); and choroidal neovascularization (1.1%). Binocular visual impairment was present in one patient (1.1%), due to complications of posterior uveitis (macular scars). Conclusions: Patients in Serbia demonstrated ocular sarcoidosis as the first most common site of extrapulmonary sarcoid manifestations, with more often neuro-ophthalmologic lesions than in other European populations. © Taylor & Francis Group, LLC.Anterior uveitisocular complicationsocular sarcoidosisposterior uveitissarcoid uveitis